DEC 17, 2018 4:05 PM PST

Alzheimer Preventing Drug Could Work Like A Vaccine

WRITTEN BY: Nouran Amin

Researchers at UT Southwestern believe that a protein called ApoE is the primary factor in late-onset Alzheimer's disease. Such conclusion has to inspired the development of a potential ‘vaccine’ drug that may be administered before age 40 for the potential prevention of the disease in about 50 to 80 percent of at-risk adults.

Learn more about Alzheimer Disease:

ApoE stands for Apolipoprotein E which carries fatty substances known as lipids and cholesterol around the brain playing an important role in repair mechanisms. Essentially, a particular subtype of the protein--ApoE4—works by promoting the accumulation of the b-amyloid protein that causes plaques seen in the brains of Alzheimer patients.

"If we can negate the ApoE4 process early, we may be able to prevent late-onset Alzheimer's altogether for many people so that they will never get sick," explains Dr. Joachim Herz, UT Southwestern molecular biologist and Alzheimer's expert.

The ApoE4 protein not only increases plaque formation in the brain but has been confirmed to suppress and trap synaptic receptors within intracellular vesicles. Researchers believe that reversing the effects of ApoE4 via pharmacological and genetic inhibition of a certain protein, NHE6, which is involved in the acidity of endosomal vesicles—will likely prevent the late-onset of Alzheimer’s disease.

A potential new drug targeting the effects of ApoE4 protein could work like a ‘vaccine’ in the prevention of Alzheimer’s disease in at-risk individuals.

Credit: UT Southwestern Medical Center

This novel therapeutic approach has been successful in mice. "The beauty of NHE6 inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer's disease just as readily available statins are able to reduce the risk of cardiovascular disease," Dr. Herz said. "Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates.”

Source: UT Southwestern Medical Center

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 13, 2020
Drug Discovery & Development
Uses of Tandem Mass Spectrometry (TMS)
OCT 13, 2020
Uses of Tandem Mass Spectrometry (TMS)
What is tandem mass spectrometry? A powerful analytical tool that is capable of characterizing complex mixtures in drug ...
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
NOV 08, 2020
Neuroscience
Psychedelic DMT Improves Memory by Neurogenesis
NOV 08, 2020
Psychedelic DMT Improves Memory by Neurogenesis
Researchers from the Complutense University of Madrid in Spain have found that dimethyltryptamine (DMT), the psychoactiv ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
NOV 30, 2020
Microbiology
Common Antibiotic Could be Effective Zika Treatment
NOV 30, 2020
Common Antibiotic Could be Effective Zika Treatment
Zika virus cause a devastating epidemic in 2015, and led to the birth of hundreds of children that had congenital brain ...
DEC 03, 2020
Drug Discovery & Development
Oregon to Create Advisory Board for Psilocybin Mushroom Therapy
DEC 03, 2020
Oregon to Create Advisory Board for Psilocybin Mushroom Therapy
Last month, Oregon became the first state in the US to legalize psilocybin mushrooms as a therapeutic treatment. Now, th ...
Loading Comments...